UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000061104 |
|---|---|
| Receipt number | R000069920 |
| Scientific Title | Relationship between bone mineral density and phase angle in patients with hip fractures |
| Date of disclosure of the study information | 2026/03/31 |
| Last modified on | 2026/03/30 15:05:43 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Relationship between bone mineral density and phase angle in patients with hip fractures
Acronym
Relationship between bone mineral density and phase angle in patients with hip fractures
Scientific Title
Relationship between bone mineral density and phase angle in patients with hip fractures
Scientific Title:Acronym
Relationship between bone mineral density and phase angle in patients with hip fractures
Region
| Japan |
Condition
Condition
hip fractures
Classification by specialty
| Orthopedics |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To clarify the relationship between bone density and phase angle in patients with hip fractures
Basic objectives2
Others
Basic objectives -Others
Predicting bone mineral density in patients with hip fractures from phase angle
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
We will analyze the relationship between bone density and phase angle using univariate analysis
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 65 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Female
Key inclusion criteria
Patients with proximal femoral fractures who visit the orthopedic outpatient clinic at Aizawa Hospital between December 1, 2025 and March 31, 2027, and who undergo DEXA evaluation based on a physician's prescription at their initial outpatient visit.
Key exclusion criteria
1.Patients undergoing conservative treatment
2.Patients for whom DEXA evaluation of the proximal femur of the healthy side cannot be performed
3.Patients with implants inserted in a hip joint other than the affected hip joint
4.Patients for whom bioelectrical impedance analysis cannot be performed (due to pacemaker implantation, infection, etc.)
5.Patients with a history of prior treatment for osteoporosis (drug therapy)
Target sample size
45
Research contact person
Name of lead principal investigator
| 1st name | Takahiro |
| Middle name | |
| Last name | Toriyama |
Organization
Aizawa Hospital
Division name
Orthopedic Rehabilitation
Zip code
390-8510
Address
2-5-1 Honjo, Matsumoto City, Nagano, Japan
TEL
0263-33-8600
riha@ai-hosp.or.jp
Public contact
Name of contact person
| 1st name | Takahiro |
| Middle name | |
| Last name | Toriyama |
Organization
Aizawa Hospital
Division name
Orthopedic Rehabilitation
Zip code
390-8510
Address
2-5-1 Honjo, Matsumoto City, Nagano, Japan
TEL
0263-33-8600
Homepage URL
riha@ai-hosp.or.jp
Sponsor or person
Institute
Aizawa Hospital
Institute
Department
Personal name
Funding Source
Organization
Nothing
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Aizawa Hospital
Address
2-5-1 Honjo, Matsumoto City, Nagano, Japan
Tel
0263-33-8600
riha@ai-hosp.or.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 03 | Month | 31 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2026 | Year | 02 | Month | 18 | Day |
Date of IRB
| 2026 | Year | 02 | Month | 18 | Day |
Anticipated trial start date
| 2026 | Year | 04 | Month | 01 | Day |
Last follow-up date
| 2028 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Single-center, prospective observational study
Management information
Registered date
| 2026 | Year | 03 | Month | 30 | Day |
Last modified on
| 2026 | Year | 03 | Month | 30 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069920
